SCHEMBL29488677

SCHEMBL29488677

COC(=O)c1ccc2[nH]c(C(F)F)nc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
KDM4E B2RXH2 4/20 0.50
LMNA P02545 3/20 0.50
HTT P42858 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
POLB P06746 1/20 0.46
RHEB Q15382 1/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
HPGD P15428 2/20 0.45
PKM P14618 1/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
CREBBP Q92793 1/20 0.45
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
HSD17B10 Q99714 1/20 0.44
PSMB8 P28062 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30349840 0.89 ALDH1A1 (0.64) ALDH1A1KDM4ELMNAHTTL3MBTL1
SCHEMBL407841 0.87 KDM4E (0.48) ALDH1A1KDM4ELMNAHTTL3MBTL1
SCHEMBL29488679 0.82 ALDH1A1 (0.51) ALDH1A1KDM4EPOLBSMN1; SMN2NPC1
SCHEMBL1170648 0.81 KDM4E (0.61) ALDH1A1KDM4ELMNAHTTL3MBTL1
SCHEMBL6295674 0.80 TAAR1 (0.55) MMP1MMP3MMP7
SCHEMBL2098919 0.80 KDM4E (0.51) ALDH1A1KDM4ELMNAHTTL3MBTL1
SCHEMBL5032566 0.80 HSP90AA1 (0.53) ALDH1A1KDM4ELMNAHTTL3MBTL1
Hydrochloric Acid SCHEMBL6295672 0.79 TAAR1 (0.54) MMP1MMP3MMP7
SCHEMBL1202574 0.78 KDM4E (0.50) ALDH1A1KDM4ELMNAHTTL3MBTL1
SCHEMBL18782890 0.78 KDM4E (0.50) ALDH1A1KDM4ELMNAHTTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114230523-A Benzimidazole derivatives as modulators of ROR-gamma 生命医药有限责任公司 2022-03-25 CN disclosed